EAH

ECO Animal Health Group plc (LON:EAH) has announced its results for the year ended 31 March 2021. HIGHLIGHTS Financials · Sales up 46% at £105.6m (2020: £72.1m) · Gross margin increased to

Eco Animal Health Group plc (LON:EAH) has issued a positive update on Group trading and the impact of a strong Chinese market on the business: ·    Group revenue and EBITDA for

ECO Animal Health Group plc (LON:EAH) has reported its results for the year ended 31 March 2020. HIGHLIGHTS Financials ·      Sales 7% higher at £72.1m (2019 restated: £67.3m) ·      Gross margin consistent

ECO Animal Health Group plc (LON:EAH) has issued a positive revenue update following the conclusion of its third quarter ended 31 December 2020 and an outlook for the year ending

ECO Animal Health Group plc (LON:EAH) has announced that it has received marketing authorisations from the United States Center for Veterinary Medicine of the Food and Drug Administration and from the

ECO Animal Health Group plc (LON:EAH) has announced that it has received a marketing authorisation from Brazil’s Ministry of Agriculture, Livestock and Food Supply for Circo/MycoGard®, a vaccine for swine. Circo/MycoGard®

ECO Animal Health Group plc (LON:EAH) has issued a positive trading update following the conclusion of its first six months ended 30 September 2020. ·    Group revenue at the half year

ECO Animal Health Group plc (LON:EAH) subsidiary ECO Animal Health Ltd has announced that it has entered two worldwide exclusive research partnerships to develop novel vaccines for use in pigs.

ECO Animal Health Group plc (LON:EAH) has announced that, as anticipated, a marketing authorisation has been received from the European Medicines Agency (EMA) for the use of Aivlosin® 625 mg/g